St. Jude Medical, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 119   

Articles published

STJ 72.62 +0.19 (0.26%)
price chart
New York: St. Jude Medical Inc (NYSE:STJ)'s Stock Had Its Buy Rating Restated ...
Out of 21 analysts covering St. Jude Medical Inc., 16 rate it a Buy, 9 indicate a Hold while 1 suggest a Sell. The highest target is $91 and the lowest is $64 according to Thomson/First Call.
Abbott Denies Report It's Preparing Bid for St. Jude Medical  Bloomberg
Drugmaker Abbott says not pursuing an offer for St Jude Medical  Reuters
Pre-Market Gainers: St. Jude Medical, Inc, Applied Genetic Technologies Corp ...
However, according to Bloomberg, Abbott spokesman mentioned that the company is not making any offer to St. Jude. The stock started to pull back after Bloomberg's report, as it is currently trading up 4.92% at $72.75, as of 9:33 AM EDT.
St. Jude Medical shares surge 13% on report Abbott Labs prepping $25 bln bid
St. Jude Medical Inc. shares STJ, +4.46% surged 12% in premarket trade Thursday, after the Financial Times reported that Abbott Laboratories ABT, +3.77% is gearing up to make a $25 billion bid for the medical device maker, citing people familiar with ...
St. Jude Medical Receives CE Mark for Industry's Only MR-Conditional ...
PAUL, Minn., Aug 24, 2015 (BUSINESS WIRE) -- St. Jude Medical, Inc. STJ, -2.35% a global medical device company, today announced CE Mark approval for magnetic resonance imaging (MRI) conditional labeling for the company's Prodigy MRI™ chronic ...
St. Jude Medical (STJ) Announces Receipt of CE Mark for Prodigy MRI with ...
St Jude Medical is Oversold
But making St Jude Medical Inc an even more interesting and timely stock to look at, is the fact that in trading on Friday, shares of STJ entered into oversold territory, changing hands as low as $68.04 per share.
St. Jude Medical Wins CE Mark Approval for Prodigy MRI
In conjunction with the approval for the Prodigy MRI system, St. Jude Medical seeks to achieve updated labeling in major markets around the world for supplementary chronic pain products.
St. Jude Medical Inc. (STJ) Pops 4.46% for August 27
One of the S&P 500's big winners for Thursday August 27 was St. Jude Medical Inc. (STJ) as the company's stock climbed 4.46% to $72.43 on volume of 8.79 million shares.
St. Jude Medical, Inc. Price Target Update
St. Jude Medical, Inc. (NYSE:STJ): 17 Brokerage firm Analysts have agreed with the mean estimate for the short term price target of $81.71 in St. Jude Medical, Inc. (NYSE:STJ). However, the stock price could fluctuate by $ 7.01 from the estimate as it ...
St. Jude Medical, Inc. (NYSE:STJ) Ratings Update  Investor Newswire
St. Jude Medical Stock Rating Lowered by Zacks (STJ)  sleekmoney
News Buzz on: Fitbit Inc(NYSE:FIT), St. Jude Medical, Inc.(NYSE:STJ), Ross ...
Fitbit, Inc., the leader in the connected health and fitness market, recently declared the Fitbit for Windows 10 app, delivering a more engaging and fluid app design that lets users personalize the way they interact with key pieces of their health and ...
St. Jude Medical Appoints David Dvorak to Its Board of Directors
St. Jude Medical is a global medical device manufacturer dedicated to transforming the treatment of some of the world's most expensive epidemic diseases.